Works matching IS 11781653 AND DT 2015 AND VI 8 AND IP 3


Results: 5
    1

    Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.

    Published in:
    Patient, 2015, v. 8, n. 3, p. 257, doi. 10.1007/s40271-015-0123-2
    By:
    • Brunetta, Jason;
    • Moreno Guillén, Santiago;
    • Antinori, Andrea;
    • Yeni, Patrick;
    • Wade, Barbara;
    • Johnson, Margaret;
    • Shalit, Peter;
    • Ebrahimi, Ramin;
    • Johnson, Bethsheba;
    • Walker, Ivan;
    • De-Oertel, Shampa
    Publication type:
    Article
    2
    3
    4
    5